Barriers to change in the informed consent process: A systematic literature review

IRB Ethics and Human Research

Volumn 38, Issue 3, 2016, Pages 1-10

  Hallinan, Zachary P ^a   Forrest, Annemarie ^b   Uhlenbrauck, Gina ^c   Young, Sheila ^d   McKinney, Ross ^e,f  

^a Center for Information and Study on Clinical Research Participation   (United States)

^b Clinical Trials Transformation Initiative (CTTI)   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

^e Department of Medicine   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL (TOPIC); HUMAN; INFORMED CONSENT; MASS COMMUNICATION; PATIENT SATISFACTION; POLICY; PROFESSIONAL STANDARD;

CLINICAL TRIALS AS TOPIC; DIFFUSION OF INNOVATION; ETHICS COMMITTEES, RESEARCH; HUMANS; INFORMED CONSENT; ORGANIZATIONAL POLICY; PATIENT SATISFACTION;

EID: 84975078674     PISSN: 01937758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. U.S. Department of Health and Human Services. Human subjects research protections: Enhancing protections for research subjects and reducing burden, delay, and ambiguity for investigators. Advance notice of proposed rulemaking. Federal Register 2011;76(143):44512-44531. http://www.hhs.gov/ohrp/humansubjects/anprm2011page.html
2. Secretary's Advisory Committee on Human Research Protections. Meeting minutes, July 21-22, 2014.
3. U.S. Department of Health and Human Services. Notice of proposed rulemaking for revisions to the Common Rule. September 2015. http://www.hhs.gov/ohrp/humansubjects/regulations/nprmhome.html.
4. Clinical Trials Transformation Initiative (CTTI). CTTI Recommendations: Informed consent. November 2015. http://www.ctti-clinicaltrials.org/what-we-do/projects/informed-consent/products.
5. Lorell BH, Mikita JS, Anderson A, et al. Informed consent in clinical research: Consensus recommendations for reform identified by an expert interview panel. Clinical Trials 2015;12(6):692-695.
6. Falagas ME, Korbila IP, Giannopoulou KP, Kondilis BK, Peppas G. Informed consent: How much and what do patients understand? American Journal of Surgery 2009;198(3):420-435.
7. Edwards SJ, Lilford RJ, Thornton J, et al. Informed consent for clinical trials: In search of the "best" method. Social Science & Medicine 1998;47(11):1825-1840
8. Kirkby HM, Calvert M, Draper H, et al. What potential research participants want to know about research: A systematic review. BMJ Open 2012;2:e000509.
9. Cohn E, Larson E. Improving participant comprehension in the informed consent process. Journal of Nursing Scholarship 2007;39(3):273-280
10. Dunn LB, Jeste DV. Enhancing informed consent for research and treatment. Neuropsychopharmacology 2001;24(6):595-607
11. Flory J, Emanuel E. Interventions to improve research participants' understanding in informed consent for research: A systematic review. JAMA. 2004;292(13):1593-1601
12. Nishimura A, Carey J, Erwin PJ et al. Improving understanding in the research informed consent process: A systematic review of 54 interventions tested in randomized control trials. BMC Medical Ethics 2013;14:28.
13. Appelbaum PS, Anatchkova M, Albert K, et al. Therapeutic misconception in research subjects: Development and validation of a measure. Clinical Trials 2012;9(6):748-761
14. Chou PHB, O'Rourke N. Development and initial validation of the Therapeutic Misunderstanding Scale for use with clinical trials research participants. Aging & Mental Health 2012;16(2):145-153
15. Hutchison C, Cowan C, Paul J. Patient understanding of research: Developing and testing of a new questionnaire. European Journal of Cancer Care 2007;16(2):187-195
16. Joffe S, Cook EF, Cleary PD, et al. Quality of informed consent: A new measure of understanding among research subjects. Journal of the National Cancer Institute 2001;93(2):139-147
17. Sugarman J, Lavori PW, Boeger M, et al. Evaluating the quality of informed consent. Clinical Trials 2005;2(1):34-41.
18. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement: Oversight of clinical research. Journal of Clinical Oncology 2003;21(12):2377-2386
19. Brody H, Miller FG. The clinician-investigator: Unavoidable but manageable tension. Kennedy Institute of Ethics Journal 2003;13(4):329-346
20. Cook D, Moore-Cox A, Xavier D et al. Randomized trials in vulnerable populations. Clinical Trials 2008;5(1):61-69
21. De Ville K, Hassler G, Lewis MJ. Rejuvenating a foundering institutional review board: One institution's story. Academic Medicine 2007;82(1):11-17
22. DeBruin DA, Liaschenko J, Fisher A. How clinical trials really work: Rethinking research ethics. Kennedy Institute of Ethics Journal 2011;21(2):121-139
23. Denzen EM, Santibáñez ME, Moore H, et al. Easy-to-read informed consent forms for hematopoietic cell transplantation clinical trials. Biology of Blood and Marrow Transplantation 2012;18(2):183-189
24. Ferguson PR. Information giving in clinical trials: The views of medical researchers. Bioethics 2003;17(1):101-111
25. Frank E, Cassano GB, Rucci P, et al. Addressing the challenges of a cross-national investigation: Lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression. Clinical Trials 2008;5(3):253-261
26. Glickman SW, Ndubuizu A, Weinfurt KP, et al. Perspective: The case for research justice: Inclusion of patients with limited English proficiency in clinical research. Academic Medicine 2011;86(3):389-393
27. Gogtay NJ, Doshi BM, Kannan S, Thatte U. A study of warning letters issued to clinical investigators and institutional review boards by the United States Food and Drug Administration. Indian Journal of Medical Ethics 2011;8(4):211-214
28. Iltis AS, Misra S, Dunn LB, et al. Addressing risks to advance mental health research. JAMA Psychiatry 2013;70(12):1363-1371
29. Kao LS, Aaron BC, Dellinger EP. Trials and tribulations: Current challenges in conducting clinical trials. Archives of Surgery 2003;138(1):59-62
30. Klitzman R. Views of the process and content of ethical reviews of HIV vaccine trials among members of US institutional review boards and South African research ethics committees. Developing World Bioethics 2008;8(3):207-218
31. Kotecha JA, Manca D, Lambert-Lanning A, et al. Ethics and privacy issues of a practice-based surveillance system: Need for a national-level institutional research ethics board and consent standards. Canadian Family Physician 2011;57(10):1165-1173
32. Koyfman SA, Agre P, Carlisle R, et al. Consent form heterogeneity in cancer trials: The cooperative group and institutional review board gap. Journal of the National Cancer Institute 2013;105(13):947-953
33. Mackin ML, Herr K, Bergen-Jackson K et al. Research participation by older adults at end of life: Barriers and solutions. Research in Gerontological Nursing 2009;2(3):162-171
34. McNay LA, Tavel JA, Oseekey K et al., for the ESPRIT Group. Regulatory approvals in a large multinational clinical trial: The ESPRIT experience. Controlled Clinical Trials 2002;23(1):59-66
35. Pogorzelska M, Stone PW, Cohn EG et al. Changes in the institutional review board submission process for multicenter research over 6 years. Nursing Outlook 2010;58(4):181-187
36. Silverman H, Hull SC, Sugarman J. Variability among institutional review boards' decisions within the context of a multicenter trial. Critical Care Medicine 2001;29(2):235-241.
37. Coyne CA, Xu R, Raich P, et al. Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: A study of the Eastern Cooperative Oncology Group. Journal of Clinical Oncology 2003;21(5):836-842
38. Hietanen PS, Aro AR, Holli KA, et al. A short communication course for physicians improves the quality of patient information in a clinical trial. Acta Oncologica 2007;46(1):42-48
39. Jefford M, Mileshkin L, Matthews J, et al. Satisfaction with the decision to participate in cancer clinical trials is high, but understanding is a problem. Supportive Care in Cancer 2011;19(3):371-379
40. Pope JE, Tingey DP, Arnold JM et al. Are subjects satisfied with the informed consent process? A survey of research participants. Journal of Rheumatology 2003;30(4):815-8241
41. Sørensen JB, Rossel P, Holm S. Patient-physician communication concerning participation in cancer chemotherapy trials. British Journal of Cancer 2004;90(2):328-332
42. Stryker JE, Wray RJ, Emmons KM et al. Understanding the decisions of cancer clinical trial participants to enter research studies: Factors associated with informed consent, patient satisfaction, and decisional regret. Patient Education and Counseling 2006;63(1-2):104-109
43. Wray RJ, Stryker JE, Winer E, et al. Do cancer patients fully understand clinical trial participation? A pilot study to assess informed consent and patient expectations. Journal of Cancer Education 2007;22(1):21-24
44. Ågård A, Hermerén G, Herlitz J. Patients' experiences of intervention trials on the treatment of myocardial infarction: Is it time to adjust the informed consent procedure to the patient's capacity? Heart 2001;86(6):632-637
45. Behrendt C, Gölz T, Roesier C, et al. What do our patients understand about their trial participation? Assessing patients' understanding of their informed consent consultation about randomised clinical trials. Journal of Medical Ethics 2011;37(2):74-80
46. Cox K. Informed consent and decision-making: Patients' experiences of the process of recruitment to phases I and II anti-cancer drug trials. Patient Education and Counseling 2002;46(1):31-38
47. Knifed E, Lipsman N, Mason W, et al. Patients' perception of the informed consent process for neurooncology clinical trials. Neuro-Oncology 2008;10(3):348-354
48. Locock L, Smith L. Personal experiences of taking part in clinical trials - a qualitative study. Patient Education and Counseling 2011;84(3):303-309
49. Sand K, Loge JH, Berger O, et al. Lung cancer patients' perceptions of informed consent documents. Patient Education and Counseling 2008;73(2):313-317.
50. Holmes-Rovner M, Kroll J, Schmitt N, et al. Patient satisfaction with health care decisions: The satisfaction with decision scale. Medical Decision Making 1996;16(1):58-64.
51. Gotay CC. Perceptions of informed consent by participants in a prostate cancer prevention study. Cancer Epidemiology, Biomarkers & Prevention 2001;10(10):1097-1099
52. Grant CH, 3rd, Cissna KN, Rosenfeld LB. Patients' perceptions of physicians communication and outcomes of the accrual to trial process. Health Communication 2000;12(1):23-39
53. Hutchison C, Cowan C, McMahon T, et al. A randomised controlled study of an audiovisual patient information intervention on informed consent and recruitment to cancer clinical trials. British Journal of Cancer 2007;97(6):705-711
54. Kenyon S, Dixon-Woods M, Jackson CJ, et al. Participating in a trial in a critical situation: A qualitative study in pregnancy. Quality & Safety in Health Care 2006;15(2):98-101
55. Kernan WN, Viscoli CM, Demarco D, et al. Boosting enrollment in neurology trials with Local Identification and Outreach Networks (LIONs). Neurology 2009;72(15):1345-1351
56. Patel A, Wilke HJ, 2nd, Mingay D et al. Patient attitudes toward granting consent to participate in perioperative randomized clinical trials. Journal of Clinical Anesthesia 2004;16(6):426-434
57. Pentz RD, Flamm AL, Sugarman J, et al. Study of the media's potential influence on prospective research participants' understanding of and motivations for participation in a high-profile phase I trial. Journal of Clinical Oncology 2002;20(18):3785-3791
58. Shannon-Dorcy K, Drevdahl DJ. "I had already made up my mind": patients and caregivers' perspectives on making the decision to participate in research at a US cancer referral center. Cancer Nursing 2011;34(6):428-433
59. Stevens T, Ahmedzai SH. Why do breast cancer patients decline entry into randomised trials and how do they feel about their decision later: A prospective, longitudinal, in-depth interview study. Patient Education and Counseling 2004;52(3):341-348
60. Wallace K, Fleshner N, Jewett M, et al. Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial. Journal of Clinical Oncology 2006;24(25):4158-4162
61. Ravina B, Swearingen C, Elm J et al. Long term understanding of study information in research participants with Parkinson's disease. Parkinsonism & Related Disorders 2010;16(1):60-63.
62. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, D.C.: Government Printing Office, 1979.
63. Grady C. Enduring and emerging challenges of informed consent. NEJM 2015;372(9):855-862
64. Menikoff J. The paradoxical problem with multiple-IRB review. NEJM 2010;363(17):1591-1593.
65. Clinical Trials Transformation Initiative. Informed Consent: Project Summary. http://www.ctti-clinicaltrials.org/what-we-do/study-start-up/informed-consent.